Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair

NCT03318445 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor, Unspecified, Adult

Interventions

DRUG: Rucaparib
DRUG: Irinotecan

Sponsor

Pamela Munster

Collaborators

[object Object]